Publications by authors named "Pascal Hammel"

Claim this Profile
T
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, Rocio Garcia-Carbonero, Olivier Bouché

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).
Marine Valery, Julien Edeline, Julie Henriques, Leony Antoun, Heloise Bourien, Pascal Hammel

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential barriers to performing adapted physical activity in patients with digestive cancer: results of the prospective observational APACADIG study.
Clémence Trihan, Cindy Richard, Emeric Boisteau, Thomas Grainville, Géraldine Perkins, Pascal Hammel

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical management of pancreatic cancer: from personalization to broadening treatment strategies.
Nelson Dusetti, Jean Baptiste Bachet, Brice Chanez, Cindy Neuzillet, Louis de Mestier, Pascal Hammel

Cancer Treat Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study).
Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, Olivier Bouché, Eric Assenat, Pascal Hammel

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of lysosomal iron triggers ferroptosis in cancer.
Tatiana Cañeque, Leeroy Baron, Sebastian Müller, Alanis Carmona, Ludovic Colombeau, Pascal Hammel

Nature· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.
Camille Evrard, Antoine Pelras, Simon Rivet, Jean-Baptiste Bachet, Olivier Dubreuil, Pascal Hammel

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric Assessment and Management, Prehabilitation and Rehabilitation for Older Aldults with Non-Colorectal Digestive Cancers.
Amélie Aregui, Janina Estrada, Madeleine Lefèvre, Anna Carteaux-Taieb, Geoffroy Beraud-Chaulet, Pascal Hammel

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
Daniel H Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Pascal Hammel

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Neuroendocrine Tumors in French VHL Mutation Carriers.
Marie Muller, Pascal Hammel, Anne Couvelard, Anne-Laure Védie, Jérôme Cros

J Clin Endocrinol Metab· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity.
Pauline Parent, Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie-Line Garcia Larnicol, Pascal Hammel

J Cachexia Sarcopenia Muscle· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort.
David Tougeron, Frederic Bibeau, Benoist Chibaudel, Stefano Kim, Thierry Nguyen, Pascal Hammel

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.
Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi, Pascal Hammel

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors.
Pascal Hammel, Denis Smith, Pauline Afchain, Sophie Dominguez-Tinajero, Jean-François Seitz

Ther Adv Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of esogastric cancer in older patients.
Thomas Aparicio, Anna Carteaux-Taieb, Amélie Arégui, Janina Estrada, Geoffroy Beraud-Chaulet, Pascal Hammel

Ther Adv Med Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study.
Alix Riescher-Tuczkiewicz, Jules Grégory, Frederic Bert, Magaly Zappa, Anna Pellat, Pascal Hammel

Ther Adv Med Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of lysosomal iron triggers ferroptosis in cancer.
Raphaël Rodriguez, Tatiana Cañeque, Leeroy Baron, Sebastian Müller, Alanis Carmona, Pascal Hammel

Res Sq· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Rémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, Juan Iovanna, Pascal Hammel

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy.
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, Rémy Nicolle, Jérôme Cros, Pascal Hammel

Lancet Gastroenterol Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Cindy Neuzillet, Olivier Bouché, Christophe Tournigand, Benoist Chibaudel, Lucile Bauguion, Pascal Hammel

J Natl Compr Canc Netw· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake.
Talia Golan, Raffaella Casolino, Andrew V Biankin, Pascal Hammel, Kristen D Whitaker

Ther Adv Med Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel.
Vincent Hautefeuille, Thomas Walter, Christine Do Cao, Romain Coriat, Sophie Dominguez, Pascal Hammel

Eur J Endocrinol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, Dimitri Pureur, François Ghiringhelli, Pascal Hammel

BMC Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948).
Mohamed Bouchahda, Ayhan Ulusakarya, Anne Thirot-Bidault, Amal Attari, Rachel Bossevot, Pascal Hammel

BMJ Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma.
Charlie Saillard, Flore Delecourt, Benoit Schmauch, Olivier Moindrot, Magali Svrcek, Pascal Hammel

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis